Analyze Diet
Parasitology2020; 147(6); 659-666; doi: 10.1017/S0031182020000189

Ascarids exposed: a method for in vitro drug exposure and gene expression analysis of anthelmintic naïve Parascaris spp.

Abstract: Ascarid parasites infect a variety of hosts and regular anthelmintic treatment is recommended for all species. Parascaris spp. is the only ascarid species with widespread anthelmintic resistance, which allows for the study of resistance mechanisms. The purpose of this study was to establish an in vitro drug exposure protocol for adult anthelmintic-naïve Parascaris spp. and report a preliminary transcriptomic analysis in response to drug exposure. Live worms were harvested from foal necropsies and maintained in RPMI-1640 at 37 °C. Serial dilutions of oxibendazole (OBZ) and ivermectin (IVM) were prepared for in vitro drug exposure, and worm viability was monitored over time. In a second drug trial, worms were used for transcriptomic analysis. The final drug concentrations employed were OBZ at 40.1 μm (10 μg mL-1) and IVM at 1.1 μm (1 μg mL-1) for 24 and 3 h, respectively. The RNA-seq analysis revealed numerous differentially expressed genes, with some being potentially related to drug detoxification and regulatory mechanisms. This report provides a method for in vitro drug exposure and the phenotypic responses for Parascaris spp., which could be extrapolated to other ascarid parasites. Finally, it also provides preliminary transcriptomic data following drug exposure as a reference point for future studies of Parascaris spp.
Publication Date: 2020-02-12 PubMed ID: 32046800PubMed Central: PMC10317622DOI: 10.1017/S0031182020000189Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research focuses on ascarid parasites and their response to anthelmintic treatment. It presents a method for in vitro drug exposure and examines genetic expression in reaction to the treatment, particularly in the Parascaris spp. variety, which shows widespread anthelmintic resistance.

Introduction to Ascarid Parasites

  • The study is centered around ascarid parasites, which are known to infect a variety of hosts. Regular anthelmintic treatment – a category of medication specifically designed to expel parasitic worms – is advised for all species.
  • Particularly, the study pays attention to the Parascaris spp. species. This species is noteworthy because it is the only ascarid species that has developed widespread resistance to anthelmintic therapies.

Purpose of the Study

  • The primary purpose of the study is the development of an in vitro (conducted in a laboratory setting) drug exposure protocol for adult anthelmintic-naïve (not previously exposed to antiparasitic drugs) Parascaris spp. The report also provides a preliminary study of how these parasites’ genes express themselves in response to drug exposure.

Methodology

  • Live worms were retrieved from foal necropsies and kept in a solution called RPMI-1640 at temperatures of 37 degrees Celsius.
  • Serial dilutions of two antiparasitic drugs, oxibendazole (OBZ) and ivermectin (IVM), were prepared for in vitro drug exposure. Throughout this procedure, worm viability was monitored.
  • In a second drug trial, worms were used for transcriptomic analysis. This analysis allows to study the full range of RNA transcripts produced by the genome under specific circumstances, in this case, the exposure to anthelminthic drugs.
  • The final drug concentrations implemented were OBZ at 40.1 μm (10 μg mL-1) and IVM at 1.1 μm (1 μg mL-1) for a span of 24 hours and 3 hours, respectively.

Results and Conclusion

  • The RNA-seq analysis, a technique to survey the presence and quantity of RNA in a biological sample, indicated several differentially expressed genes, some of which might be tied to drug detoxification processes and regulatory systems within the parasite.
  • The study provides a model for the use of in vitro drug exposure and the phenotypic (observable physical traits) responses for Parascaris spp.
  • This method could potentially be extrapolated and applied to the study of other ascarid parasites.
  • Lastly, the study serves as a preliminary reference point for future transcriptomic studies related to Parascaris spp. post-drug exposure, and it points towards the possibility of using this approach to better understand the mechanisms behind drug resistance in parasites.

Cite This Article

APA
Scare JA, Dini P, Norris JK, Steuer AE, Scoggin K, Gravatte HS, Howe DK, Slusarewicz P, Nielsen MK. (2020). Ascarids exposed: a method for in vitro drug exposure and gene expression analysis of anthelmintic naïve Parascaris spp. Parasitology, 147(6), 659-666. https://doi.org/10.1017/S0031182020000189

Publication

ISSN: 1469-8161
NlmUniqueID: 0401121
Country: England
Language: English
Volume: 147
Issue: 6
Pages: 659-666

Researcher Affiliations

Scare, J A
  • Department of Veterinary Science, M.H. Gluck Equine Research Center, University of Kentucky, Lexington, KY, USA.
Dini, P
  • Department of Veterinary Science, M.H. Gluck Equine Research Center, University of Kentucky, Lexington, KY, USA.
Norris, J K
  • Department of Veterinary Science, M.H. Gluck Equine Research Center, University of Kentucky, Lexington, KY, USA.
Steuer, A E
  • Department of Veterinary Science, M.H. Gluck Equine Research Center, University of Kentucky, Lexington, KY, USA.
Scoggin, K
  • Department of Veterinary Science, M.H. Gluck Equine Research Center, University of Kentucky, Lexington, KY, USA.
Gravatte, H S
  • Department of Veterinary Science, M.H. Gluck Equine Research Center, University of Kentucky, Lexington, KY, USA.
Howe, D K
  • Department of Veterinary Science, M.H. Gluck Equine Research Center, University of Kentucky, Lexington, KY, USA.
Slusarewicz, P
  • MEP Equine Solutions, 3905 English Oak Circle, Lexington, KY40514, USA.
Nielsen, M K
  • Department of Veterinary Science, M.H. Gluck Equine Research Center, University of Kentucky, Lexington, KY, USA.

MeSH Terms

  • Animals
  • Anthelmintics / pharmacology
  • Ascaridoidea / drug effects
  • Ascaridoidea / genetics
  • Drug Resistance / genetics
  • Gene Expression
  • Gene Expression Profiling
  • Genes, Helminth
  • In Vitro Techniques
  • RNA-Seq
  • Transcriptome

References

This article includes 40 references
  1. Armstrong SK, Woodgate RG, Gough S, Heller J, Sangster NC, Hughes KJ. The efficacy of ivermectin, pyrantel and fenbendazole against Parascaris equorum infection in foals on farms in Australia.. Veterinary Parasitology 205, 575–580.
    pubmed: 25224788
  2. Beech RN, Skuce P, Bartley DJ, Martin RJ, Prichard RK, Gilleard JS. Anthelmintic resistance: markers for resistance, or susceptibility?. Parasitology 138, 160–174.
    pmc: PMC3064440pubmed: 20825689
  3. Chelladurai JJ, Brewer MT. Detection and quantification of Parascaris P-glycoprotein drug transporter expression with a novel mRNA hybridization technique.. Veterinary Parasitology 267, 75–83.
    pubmed: 30878090
  4. Cvilink V, Lamka J, Skálová L. Xenobiotic metabolizing enzymes and metabolism of anthelmintics in helminths.. Drug Metabolism Reviews 41, 8–26.
    pubmed: 19514969
  5. Feyereisen R. Insect P450 enzymes.. Annual Review of Entomology 44, 507–533.
    pubmed: 9990722
  6. Hanser E, Mehlhorn H, Hoeben D, Vlaminck K. In vitro studies on the effects of flubendazole against Toxocara canis and Ascaris suum.. Parasitology Research 89(1), 63–74.
    doi: 10.1007/s00436-002-0668-6pubmed: 12474046google scholar: lookup
  7. Hu Y, Ellis BL, Yiu YY, Miller MM, Urban JF, Shi LZ, Aroian RV. An extensive comparison of the effect of anthelmintic classes on diverse nematodes.. PLoS ONE 8, 1–12.
    pmc: PMC3712009pubmed: 23869246
  8. Ikenouchi J, Umeda M. FRMD4A regulates epithelial polarity by connecting Arf6 activation with the PAR complex.. Proceedings of the National Academy of Sciences 107, 2–7.
    pmc: PMC2818900pubmed: 20080746
  9. James CE, Hudson AL, Davey MW. Drug resistance mechanisms in helminths: is it survival of the fittest?. Trends in Parasitology 25, 328–335.
    pubmed: 19541539
  10. Janssen IJI, Krücken J, Demeler J, Basiaga M, Kornaś S, von Samson-Himmelstjerna G. Genetic variants and increased expression of Parascaris equorum P-glycoprotein-11 in populations with decreased ivermectin susceptibility.. PLoS ONE 8, 1–10.
  11. Janssen IJI, Krücken J, Demeler J, von Samson-Himmelstjerna G. Transgenically expressed Parascaris P-glycoprotein-11 can modulate ivermectin susceptibility in Caenorhabditis elegans.. International Journal for Parasitology: Drugs and Drug Resistance 5, 44–47.
    pmc: PMC4401813pubmed: 25905032
  12. Jourdan PM, Lamberton PHL, Fenwick A, Addiss DG. Soil-transmitted helminth infections.. Lancet 391, 252–265.
    pubmed: 28882382
  13. Kaplan RM. Drug resistance in nematodes of veterinary importance: a status report.. Trends in Parasitology 20, 477–481.
    pubmed: 15363441
  14. Kilpinen O, Roepstorff A, Permit A, Norgaard-Nielsen G, Lawson LG, Simonsen HB. Influence of Dermanyssus gallinae and Ascaridia Galli infections on behavior and health of laying hens (Gallus Gallus domesticus).. British Poultry Science 46, 26–34.
    pubmed: 15835249
  15. Kotze AC, Hunt PW, Skuce P, von Samson-Himmelstjerna G, Martin RJ, Sager H, Krücken J, Hodgkinson J, Lespine A, Jex AR, Gilleard JS, Beech RN, Wolstenholme AJ, Demeler J, Robertson AP, Charvet CL, Neveu C, Kaminsky R, Rufener L, Alberich M, Menez C, Prichard RK. Recent advances in candidate-gene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug/receptor interactions.. International Journal for Parasitology: Drugs and Drug Resistance 4, 164–184.
    pmc: PMC4266812pubmed: 25516826
  16. Krücken J, Fraundorfer K, Mugisha JC, Ramünke S, Sifft KC, Geus D, Habarugira F, Ndoli J, Sendegeya A, Mukampunga C, Bayingana C, Aebischer T, Demeler J, Gahutu JB, Mockenhaupt FP, von Samson-Himmelstjerna G. Reduced efficacy of albendazole against Ascaris lumbricoides in Rwandan schoolchildren.. International Journal for Parasitology: Drugs and Drug Resistance 7(3), 262–271.
  17. Lacey E. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles.. International Journal for Parasitology 18, 885–936.
    pubmed: 3066771
  18. Laurent GS, Shtokalo D, Tackett MR, Yang Z, Vyatkin Y, Milos PM, Seilheimer B, McCaffrey TA, Kapranov P. On the importance of small changes in RNA expression.. Methods 63, 18–24.
    pubmed: 23563143
  19. Lecová L, Růžičková M, Laing R, Vogel H, Szotáková B, Prchal L, Lamka J, Vokřál I, Skálová L, Matoušková P. Reliable reference gene selection for quantitative real time PCR in Haemonchus contortus.. Molecular and Biochemical Parasitology 201, 123–127.
    pubmed: 26255779
  20. Lesage F, Lazdunski M. Molecular and functional properties of two-pore-domain potassium channels.. American Journal of Physiology-Renal Physiology 279, F793–F801.
    pubmed: 11053038
  21. Lloberas M, Alvarez L, Entrocasso C, Ballent M, Virkel G, Luque S, Lanusse C, Lifschitz A. Comparative pharmacokinetic and pharmacodynamic response of single and double intraruminal doses of ivermectin and moxidectin in nematode-infected lambs.. New Zealand Veterinary Journal 63, 227–234.
    pubmed: 25689407
  22. Lyons ET, Drudge JH, Tolliver SC. Prevalence of some internal parasites found (1971–1989) in horses born on a farm in Central Kentucky.. Journal of Equine Veterinary Science 10, 99–107.
  23. Lyons ET, Tolliver SC, Ionita M, Collins SS. Evaluation of parasiticidal activity of fenbendazole, ivermectin, oxibendazole, and pyrantel pamoate in horse foals with emphasis on ascarids (Parascaris equorum) in field studies on five farms in Central Kentucky in 2007.. Parasitology Research 103, 287–291.
    pubmed: 18470536
  24. Lyons ET, Tolliver SC, Kuzmina TA, Collins SS. Further evaluation in field tests of the activity of three anthelmintics (fenbendazole, oxibendazole, and pyrantel pamoate) against the ascarid Parascaris equorum in horse foals on eight farms in Central Kentucky (2009–2010).. Parasitology Research 109, 1193–1197.
    pubmed: 21499750
  25. Martin RJ. Modes of action of anthelmintic drugs.. Veterinary Journal 154, 11–34.
    pubmed: 9265850
  26. Martin F, Höglund J, Bergström TF, Karlsson Lindsjö O, Tydén E. Resistance to pyrantel embonate and efficacy of fenbendazole in Parascaris univalens on Swedish stud farms.. Veterinary Parasitology 264, 69–73.
    pubmed: 30503095
  27. Meng W, Takeichi M. Adherens junction: molecular architecture and regulation.. Cold Spring Harbor Perspectives in Biology 1, a002899.
    pmc: PMC2882120pubmed: 20457565
  28. Mi H, Muruganujan A, Casagrande JT, Thomas PD. Large-scale gene function analysis with the PANTHER-classification system.. Nature Protocols 8, 1551–1566.
    pmc: PMC6519453pubmed: 23868073
  29. Mi H, Huang X, Muruganujan A, Tang H, Mills C, Kang D, Thomas PD. PANTHER Version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements.. Nucleic Acids Research 45, D183–D189.
    pmc: PMC5210595pubmed: 27899595
  30. Nielsen MK. Evidence-based considerations for control of Parascaris Spp. infections in horses.. Equine Veterinary Education 28, 224–231.
  31. Overgaauw PAM. Aspects of Toxocara epidemiology: toxocarosis in dogs and cats.. Critical Reviews in Microbiology 23, 233–251.
    pubmed: 9347222
  32. Peregrine AS, Molento MB, Kaplan RM, Nielsen MK. Anthelmintic resistance in important parasites of horses: does it really matter?. Veterinary Parasitology 201, 1–8.
    pubmed: 24485565
  33. Perez de la Cruz I, Levin JZ, Cummins C, Anderson P, Horvitz HR. sup-9, sup-10, and unc-93 may encode components of a two-pore K+ channel that coordinates muscle contraction in Caenorhabditis elegans.. Journal of Neuroscience 23, 9133–9145.
    pmc: PMC6740817pubmed: 14534247
  34. Scare JA, Steuer AE, Shaffer CL, Slusarewicz P, Mousley A, Nielsen MK. Long live the worms: methods for maintaining and assessing the viability of intestinal stages of Parascaris Spp. in vitro.. Parasitology 18, 1–9.
    pubmed: 30561286
  35. Stehbens SJ, Paterson AD, Crampton MS, Shewan AM, Ferguson C, Akhmanova A, Parton RG, Yap AS. Dynamic microtubules regulate the local concentration of E-cadherin at cell-cell contacts.. Journal of Cell Science 119, 1801–1811.
    pubmed: 16608875
  36. Thamsborg SM, Nejsum P, Mejer H. Impact of Ascaris suum in livestock.. In Holland Celia (ed.), Ascaris the Neglected Parasite. Waltham, MA: Elsevier, pp. 363–381 .
  37. Wang J, Gao S, Mostovoy Y, Kang Y, Zagoskin M, Sun Y, Zhang B, White LK, Easton A, Nutman TB, Kwok PY, Hu S, Nielsen MK, Davis RE. Comparative genome analysis of programmed DNA elimination in nematodes.. Genome Research 27, 2001–2014.
    pmc: PMC5741062pubmed: 29118011
  38. Wolstenholme AJ. Glutamate-gated chloride channels.. The Journal of Biological Chemistry 287, 40232–40238.
    pmc: PMC3504739pubmed: 23038250
  39. Yazwinski TA, Tucker CA, Wray E, Jones L, Clark FD. Observations of benzimidazole efficacies against Ascaridia dissimilis, Ascaridia galli, and Heterakis gallinarum in naturally infected poultry.. Journal of Applied Poultry Research 22(1), 75–79.
    doi: 10.3382/japr.2012-00606google scholar: lookup
  40. Yilmaz E, Ramünke S, Demeler J, Krücken J. Comparison of constitutive and thiabendazole-induced expression of five cytochrome P450 genes in fourth-stage larvae of Haemonchus contortus isolates with different drug susceptibility identifies one gene with high constitutive expression in a multi-resistance.. International Journal for Parasitology: Drugs and Drug Resistance 7, 362–369.
    pmc: PMC5645160pubmed: 29035734